{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["epithelial cell", "gene regulation", "natural inducer", "synergistic effect", "\u03b2-defensin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30275324", "DateCompleted": {"Year": "2018", "Month": "12", "Day": "17"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "01"}], "Language": ["eng"], "ELocationID": ["10.1073/pnas.1805298115"], "Journal": {"ISSN": "1091-6490", "JournalIssue": {"Volume": "115", "Issue": "42", "PubDate": {"Year": "2018", "Month": "Oct", "Day": "16"}}, "Title": "Proceedings of the National Academy of Sciences of the United States of America", "ISOAbbreviation": "Proc Natl Acad Sci U S A"}, "ArticleTitle": "Natural molecules induce and synergize to boost expression of the human antimicrobial peptide \u03b2-defensin-3.", "Pagination": {"StartPage": "E9869", "EndPage": "E9878", "MedlinePgn": "E9869-E9878"}, "Abstract": {"AbstractText": ["Antimicrobial peptides (AMPs) are mucosal defense effectors of the human innate immune response. In the intestine, AMPs are produced and secreted by epithelial cells to protect the host against pathogens and to support homeostasis with commensals. The inducible nature of AMPs suggests that potent inducers could be used to increase their endogenous expression for the prevention or treatment of diseases. Here we aimed at identifying molecules from the natural pharmacopoeia that induce expression of human \u03b2-defensin-3 (HBD3), one of the most efficient AMPs, without modifying the production of proinflammatory cytokines. By screening, we identified three molecules isolated from medicinal plants, andrographolide, oridonin, and isoliquiritigenin, which induced HBD3 production in human colonic epithelial cells. This effect was observed without activation of the NF-\u03baB pathway or the expression of associated proinflammatory cytokines. We identified the EGF receptor as the target of these compounds and characterized the downstream-activated MAPK pathways. At the chromatin level, molecules increased phosphorylation of histone H3 on serine S10 and recruitment of the c-Fos, c-Jun, and Elk1 or c-Myc transcription factors at the HBD3 promoter. Interestingly, stimulating cells with a combination of andrographolide and isoliquiritigenin synergistically enhanced HBD3 induction 10-fold more than observed with each molecule alone. Finally, we investigated the molecular basis governing the synergistic effect, confirmed our findings in human colonic primary cells, and demonstrated that synergism increased cellular antimicrobial activity. This work shows the capability of small molecules to achieve induction of epithelial antimicrobial defenses while simultaneously avoiding the deleterious risks of an inflammatory response."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e9 de Pathog\u00e9nie Microbienne Mol\u00e9culaire, Institut Pasteur, 75015 Paris, France."}, {"Identifier": [], "Affiliation": "Unit\u00e9 INSERM U1202, Institut Pasteur, 75015 Paris, France."}], "LastName": "Sechet", "ForeName": "Emmanuel", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e9 de Pathog\u00e9nie Microbienne Mol\u00e9culaire, Institut Pasteur, 75015 Paris, France."}, {"Identifier": [], "Affiliation": "Unit\u00e9 INSERM U1202, Institut Pasteur, 75015 Paris, France."}], "LastName": "Telford", "ForeName": "Erica", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e9 de Pathog\u00e9nie Microbienne Mol\u00e9culaire, Institut Pasteur, 75015 Paris, France."}, {"Identifier": [], "Affiliation": "Unit\u00e9 INSERM U1202, Institut Pasteur, 75015 Paris, France."}], "LastName": "Bonamy", "ForeName": "Cl\u00e9ment", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e9 de Pathog\u00e9nie Microbienne Mol\u00e9culaire, Institut Pasteur, 75015 Paris, France; philippe.sansonetti@pasteur.fr brice.sperandio@pasteur.fr."}, {"Identifier": [], "Affiliation": "Unit\u00e9 INSERM U1202, Institut Pasteur, 75015 Paris, France."}, {"Identifier": [], "Affiliation": "Chaire de Microbiologie et Maladies Infectieuses, Coll\u00e8ge de France, 75005 Paris, France."}], "LastName": "Sansonetti", "ForeName": "Philippe J", "Initials": "PJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e9 de Pathog\u00e9nie Microbienne Mol\u00e9culaire, Institut Pasteur, 75015 Paris, France; philippe.sansonetti@pasteur.fr brice.sperandio@pasteur.fr."}, {"Identifier": [], "Affiliation": "Unit\u00e9 INSERM U1202, Institut Pasteur, 75015 Paris, France."}], "LastName": "Sperandio", "ForeName": "Brice", "Initials": "B"}], "GrantList": [{"Acronym": "HHMI", "Agency": "Howard Hughes Medical Institute", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Proc Natl Acad Sci U S A", "NlmUniqueID": "7505876", "ISSNLinking": "0027-8424"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "DEFB103A protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Diterpenes, Kaurane"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "beta-Defensins"}, {"RegistryNumber": "0APJ98UCLQ", "NameOfSubstance": "oridonin"}, {"RegistryNumber": "410105JHGR", "NameOfSubstance": "andrographolide"}, {"RegistryNumber": "B9CTI9GB8F", "NameOfSubstance": "isoliquiritigenin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bacteria"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chalcones"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Colon"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Diterpenes"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Diterpenes, Kaurane"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Immunity, Innate"}, {"QualifierName": ["metabolism"], "DescriptorName": "beta-Defensins"}], "CoiStatement": "Conflict of interest statement: C.B. is a recipient of a Sanofi-funded PhD fellowship in the context of the French private\u2013public partnership Convention Industrielle de Formation par la Recherche (CIFRE) program."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sansonetti PJ. The innate signaling of dangers and the dangers of innate signaling. Nat Immunol. 2006;7:1237\u20131242.", "ArticleIdList": ["17110939"]}, {"Citation": "Janeway CA, Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197\u2013216.", "ArticleIdList": ["11861602"]}, {"Citation": "Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science. 1999;284:1313\u20131318.", "ArticleIdList": ["10334979"]}, {"Citation": "Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389\u2013395.", "ArticleIdList": ["11807545"]}, {"Citation": "Ganz T. Defensins: Antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710\u2013720.", "ArticleIdList": ["12949495"]}, {"Citation": "Vaishnava S, et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science. 2011;334:255\u2013258.", "ArticleIdList": ["PMC3321924", "21998396"]}, {"Citation": "Radek K, Gallo R. Antimicrobial peptides: Natural effectors of the innate immune system. Semin Immunopathol. 2007;29:27\u201343.", "ArticleIdList": ["17621952"]}, {"Citation": "Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol. 2004;22:181\u2013215.", "ArticleIdList": ["15032578"]}, {"Citation": "Brogden KA. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3:238\u2013250.", "ArticleIdList": ["15703760"]}, {"Citation": "Giacometti A, et al. Potential therapeutic role of cationic peptides in three experimental models of septic shock. Antimicrob Agents Chemother. 2002;46:2132\u20132136.", "ArticleIdList": ["PMC127283", "12069965"]}, {"Citation": "Rivas-Santiago B, Serrano CJ, Enciso-Moreno JA. Susceptibility to infectious diseases based on antimicrobial peptide production. Infect Immun. 2009;77:4690\u20134695.", "ArticleIdList": ["PMC2772553", "19703980"]}, {"Citation": "Hancock REW, Sahl H-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006;24:1551\u20131557.", "ArticleIdList": ["17160061"]}, {"Citation": "Fox JL. Antimicrobial peptides stage a comeback. Nat Biotechnol. 2013;31:379\u2013382.", "ArticleIdList": ["23657384"]}, {"Citation": "Marr AK, Gooderham WJ, Hancock RE. Antibacterial peptides for therapeutic use: Obstacles and realistic outlook. Curr Opin Pharmacol. 2006;6:468\u2013472.", "ArticleIdList": ["16890021"]}, {"Citation": "Abdelmohsen UR, et al. Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections. Lancet Infect Dis. 2017;17:e30\u2013e41.", "ArticleIdList": ["27979695"]}, {"Citation": "Nakajima S, et al. Fungus-derived neoechinulin B as a novel antagonist of liver X receptor, identified by chemical genetics using a hepatitis C virus cell culture system. J Virol. 2016;90:9058\u20139074.", "ArticleIdList": ["PMC5044839", "27489280"]}, {"Citation": "Chen X, et al. Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin. Eur J Med Chem. 2015;93:182\u2013195.", "ArticleIdList": ["25681711"]}, {"Citation": "Kim K-S, et al. Anti-inflammatory effect of neoechinulin a from the marine fungus Eurotium sp. SF-5989 through the suppression of NF-\u043aB and p38 MAPK pathways in lipopolysaccharide-stimulated RAW264.7 macrophages. Molecules. 2013;18:13245\u201313259.", "ArticleIdList": ["PMC6270177", "24165583"]}, {"Citation": "Gu S, Pei J. Innovating chinese herbal medicine: From traditional health practice to scientific drug discovery. Front Pharmacol. 2017;8:381.", "ArticleIdList": ["PMC5472722", "28670279"]}, {"Citation": "Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21:E559.", "ArticleIdList": ["PMC6273146", "27136524"]}, {"Citation": "Tan WSD, Liao W, Zhou S, Wong WSF. Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action. Biochem Pharmacol. 2017;139:71\u201381.", "ArticleIdList": ["28377280"]}, {"Citation": "Owona BA, Schluesener HJ. Molecular insight in the multifunctional effects of oridonin. Drugs R D. 2015;15:233\u2013244.", "ArticleIdList": ["PMC4561052", "26290464"]}, {"Citation": "Peng F, et al. A review: The pharmacology of isoliquiritigenin. Phytother Res. 2015;29:969\u2013977.", "ArticleIdList": ["25907962"]}, {"Citation": "Chantret I, et al. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: Evidence for glucose-dependent negative regulation. J Cell Sci. 1994;107:213\u2013225.", "ArticleIdList": ["8175910"]}, {"Citation": "Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195\u20132224.", "ArticleIdList": ["15371334"]}, {"Citation": "S\u00f8rensen OE, et al. Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol. 2005;174:4870\u20134879.", "ArticleIdList": ["15814714"]}, {"Citation": "Hubbard SR, Miller WT. Receptor tyrosine kinases: Mechanisms of activation and signaling. Curr Opin Cell Biol. 2007;19:117\u2013123.", "ArticleIdList": ["PMC2536775", "17306972"]}, {"Citation": "Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel) 2017;9:E52.", "ArticleIdList": ["PMC5447962", "28513565"]}, {"Citation": "Saccani S, Pantano S, Natoli G. p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol. 2002;3:69\u201375.", "ArticleIdList": ["11743587"]}, {"Citation": "Arbibe L, et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol. 2007;8:47\u201356.", "ArticleIdList": ["17159983"]}, {"Citation": "Fischer N, et al. Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge. Proc Natl Acad Sci USA. 2016;113:E2993\u2013E3001.", "ArticleIdList": ["PMC4889416", "27162363"]}, {"Citation": "Sato T, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology. 2011;141:1762\u20131772.", "ArticleIdList": ["21889923"]}, {"Citation": "Weake VM, Workman JL. Inducible gene expression: Diverse regulatory mechanisms. Nat Rev Genet. 2010;11:426\u2013437.", "ArticleIdList": ["20421872"]}, {"Citation": "Donnarumma G, et al. Effects of AV119, a natural sugar from avocado, on Malassezia furfur invasiveness and on the expression of HBD-2 and cytokines in human keratinocytes. Exp Dermatol. 2007;16:912\u2013919.", "ArticleIdList": ["17927574"]}, {"Citation": "Sass V, et al. Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun. 2010;78:2793\u20132800.", "ArticleIdList": ["PMC2876548", "20385753"]}, {"Citation": "Paoletti I, et al. Patented natural avocado sugar modulates the HBD-2 and HBD-3 expression in human keratinocytes through toll-like receptor-2 and ERK/MAPK activation. Arch Dermatol Res. 2012;304:619\u2013625.", "ArticleIdList": ["22526324"]}, {"Citation": "Zhao Y, et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol. 2018;11:752\u2013762.", "ArticleIdList": ["PMC5976519", "29411774"]}, {"Citation": "Li D, et al. A novel lipopeptide from skin commensal activates TLR2/CD36-p38 MAPK signaling to increase antibacterial defense against bacterial infection. PLoS One. 2013;8:e58288.", "ArticleIdList": ["PMC3589260", "23472173"]}, {"Citation": "Fehlbaum P, Rao M, Zasloff M, Anderson GM. An essential amino acid induces epithelial beta -defensin expression. Proc Natl Acad Sci USA. 2000;97:12723\u201312728.", "ArticleIdList": ["PMC18831", "11058160"]}, {"Citation": "Raqib R, et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci USA. 2006;103:9178\u20139183.", "ArticleIdList": ["PMC1482586", "16740661"]}, {"Citation": "Prenzel N, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402:884\u2013888.", "ArticleIdList": ["10622253"]}, {"Citation": "Leahy DJ. Structure and function of the epidermal growth factor (EGF/ErbB) family of receptors. Adv Protein Chem. 2004;68:1\u201327.", "ArticleIdList": ["15500857"]}, {"Citation": "Krall JA, Beyer EM, MacBeath G. High- and low-affinity epidermal growth factor receptor-ligand interactions activate distinct signaling pathways. PLoS One. 2011;6:e15945.", "ArticleIdList": ["PMC3018525", "21264347"]}, {"Citation": "Boughan PK, et al. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: Critical regulators of beta-defensins during Helicobacter pylori infection. J Biol Chem. 2006;281:11637\u201311648.", "ArticleIdList": ["16513653"]}, {"Citation": "Dhople V, Krukemeyer A, Ramamoorthy A. The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim Biophys Acta. 2006;1758:1499\u20131512.", "ArticleIdList": ["16978580"]}, {"Citation": "Darveau RP, et al. Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother. 1991;35:1153\u20131159.", "ArticleIdList": ["PMC284303", "1929257"]}, {"Citation": "Maisetta G, et al. Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria. Antimicrob Agents Chemother. 2003;47:3349\u20133351.", "ArticleIdList": ["PMC201125", "14506056"]}, {"Citation": "Tarleton JL, et al. Cognitive effects of diarrhea, malnutrition, and Entamoeba histolytica infection on school age children in Dhaka, Bangladesh. Am J Trop Med Hyg. 2006;74:475\u2013481.", "ArticleIdList": ["16525109"]}, {"Citation": "Wierzba TF, et al. The interrelationship of malnutrition and diarrhea in a periurban area outside Alexandria, Egypt. J Pediatr Gastroenterol Nutr. 2001;32:189\u2013196.", "ArticleIdList": ["11321391"]}, {"Citation": "Fellermann K, Wehkamp J, Herrlinger KR, Stange EF. Crohn\u2019s disease: A defensin deficiency syndrome? Eur J Gastroenterol Hepatol. 2003;15:627\u2013634.", "ArticleIdList": ["12840673"]}, {"Citation": "Wiest R, Rath HC. Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol. 2003;17:397\u2013425.", "ArticleIdList": ["12763504"]}, {"Citation": "Midorikawa K, et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun. 2003;71:3730\u20133739.", "ArticleIdList": ["PMC162002", "12819054"]}]}], "History": [{"Year": "2018", "Month": "10", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30275324", "PMC6196494", "10.1073/pnas.1805298115", "1805298115"]}}]}